ABOUT THIS EPISODE

English
United States

TRANSCRIPT 🔗

SEARCH PAST EPISODES

Search past episodes of From Pathogen to Infectious Disease Diagnosis.

OTHER EPISODES IN THIS PODCAST

A new multiplex blood-screening assay is streamlining transfusion safety by enabling simultaneous detection and discrimination of HIV, HBV, HCV, and hepatitis E in a single test, helping laboratories improve efficiency, reduce turnaround times, and strengthen blood supply resilience amid ongoing do…
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Artificial intelligence is increasingly reshaping clinical decision-making, and a new generation of point-of-care tools is targeting one of healthcare’s most persistent challenges: antimicrobial stewardship. In a recent podcast discussion, Eolas Medical Founder and CEO Declan Kelly, MBBS, outline…
FDA-cleared single-step immunoblot tests built on recombinant antigens from multiple Borrelia species detected nearly twice as many early Lyme disease cases as standard two-tier testing. Joseph J. Burrascano Jr, MD, offers insights into what the new tests mean for clinicians.
Disclaimer: The podcast and artwork embedded on this page are from Contagion, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.